Oramed Pharmaceuticals ORMP Growth Metrics (2011-2026)

NASDAQ ORMP
$4.13 -0.02 (-0.48%)
As of: Oct 21, 2026 · 2:19 PM EDT
Reported Financials

Oramed Pharmaceuticals Quarterly Growth Metrics

Periods 61 quarters
Latest Jun 2026

Oramed Pharmaceuticals reported asset growth of 128.62% for the quarter ended Jun 2026. These growth metrics cover 61 quarters of results from Feb 2011 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y)
74.39%186.78%345.31%-7.23%-3.68%40.41%36.44%27.46%17.85%-28.50%-29.60%-27.55%-12.23%33.57%48.68%82.22%128.62%
Assets Growth (3y)
32.43%39.26%61.15%-5.03%-0.12%10.27%12.62%18.94%33.23%
Assets Growth (5y)
17.26%24.48%32.35%
Assets (QoQ)
30.55%59.02%42.54%-5.77%1.32%-1.70%-1.15%-2.17%47.71%-4.48%-7.66%-9.54%-10.39%-5.94%-4.98%9.59%36.37%4.70%16.45%37.49%
Capital Expenditures Growth (1y)Capex Growth (1y)
323.40%0.00%-73.55%-99.03%-98.99%-84.38%266.67%50.00%-81.82%66.67%-50.00%
Capital Expenditures Growth (3y)Capex Growth (3y)
-60.04%-41.52%-81.34%-70.71%-53.58%
Capital Expenditures Growth (5y)Capex Growth (5y)
-22.16%
Capital Expenditures (QoQ)Capex (QoQ)
-93.94%-57.45%505.00%154.55%-35.39%-89.95%60.00%-90.63%-33.33%120.00%-72.73%33.33%150.00%-60.00%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
516.49%300.32%113.52%-77.62%500.99%301.14%-15.57%-82.28%-3.49%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
150.03%149.12%102.12%4.33%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
77.03%81.64%69.33%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
69.84%34.54%-58.73%105.15%36.93%-78.80%230.31%-11.94%-71.27%15.47%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
155.86%-8,360.88%-279.41%-241.95%-6,212.45%166.40%327.21%743.47%54.39%-48.58%-21.27%-157.95%211.98%-110.92%-182.52%107.86%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
23.77%-227.33%47.50%-93.93%214.86%-29.06%-13.86%31.87%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
26.95%-95.87%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
323.38%40.82%-88.14%816.19%-217.26%-11.41%-410.69%139.93%0.00%215.54%-136.19%145.02%53.11%-332.27%169.94%-104.39%-1,057.24%122.12%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-67.95%-12.21%39.19%68.98%69.03%82.41%73.40%178.82%-923.20%-34.77%-138.41%-270.28%77.12%75.61%17.16%94.34%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-14.00%-18.67%27.21%25.33%10.16%61.34%19.31%57.65%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-20.44%-45.89%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
-73.53%6.96%73.60%-259.75%31.17%52.53%73.65%-104.32%-4.09%240.65%-442.05%73.09%-84.14%-0.45%54.03%71.32%-525.54%93.14%
Dividends payables (QoQ)
-97.14%-12.87%
EBITDA Margin Growth (1y)
0.09M0.11M
EBITDA Margin Growth (3y)
0.15M
EBITDA Margin (QoQ)
-385.000.05M-0.02M0.06M0.02M
EBIT Growth (1y)
53.71%66.80%64.67%68.55%43.13%17.30%-6.77%7.27%-51.92%20.61%21.43%-57.77%18.69%-11.13%
EBIT Growth (3y)
26.32%39.81%33.33%22.80%11.10%9.97%
EBIT Growth (5y)
EBIT Margin Growth (1y)
0.09M0.11M
EBIT Margin Growth (3y)
0.15M
EBIT Margin (QoQ)
-443.000.05M-0.02M0.06M0.02M
EBIT (QoQ)
-1.47%28.27%-50.52%57.75%27.21%23.69%-34.01%23.60%-5.84%1.47%-16.38%-25.17%44.69%2.49%-133.70%35.49%24.41%
EBT Growth (1y)
66.28%88.14%54.09%208.49%142.48%925.44%-463.61%-173.58%-560.10%21.18%421.20%200.14%800.48%673.47%
EBT Growth (3y)
12.97%47.16%117.66%40.94%150.35%329.75%
EBT Growth (5y)
EBT Margin Growth (1y)
0.11M0.14M
EBT Margin Growth (3y)
0.13M
EBT Margin (QoQ)
0.00M0.06M-0.03M0.08M0.03M
EBT (QoQ)
-3.35%35.37%-71.33%70.53%63.64%-150.11%504.87%-88.46%606.52%-270.78%47.14%27.85%286.09%352.65%-83.52%404.64%105.48%
EPS (Basic) Growth (1y)
68.54%89.07%55.88%206.94%144.36%857.70%-502.19%-178.00%-592.79%41.54%341.60%196.87%606.90%498.24%
EPS (Basic) Growth (3y)
11.73%46.94%103.43%41.08%135.62%304.45%
EPS (Basic) Growth (5y)
EPS (Basic) (QoQ)
-0.73%33.50%-65.70%71.66%64.99%-168.38%501.64%-88.24%497.93%-313.30%47.98%25.73%271.74%264.09%-79.14%288.66%102.68%
EPS (Diluted) Growth (1y)
68.54%89.07%55.88%206.27%143.59%846.20%-502.19%-178.48%-601.57%40.80%335.85%194.55%592.45%489.67%
EPS (Diluted) Growth (3y)
11.73%46.57%102.19%40.76%133.71%299.90%
EPS (Diluted) (QoQ)
-0.73%33.50%-65.70%71.66%64.99%-168.38%499.15%-88.38%499.35%-316.59%47.98%25.73%268.25%262.80%-79.14%286.85%101.46%
FCF Margin Growth (1y)
0.05M0.09M
FCF Margin Growth (3y)
0.12M
FCF Margin (QoQ)
0.01M0.09M-0.06M0.01M0.05M
Free Cash Flow Growth (1y)FCF Growth (1y)
-68.01%-6.77%37.33%68.81%69.26%83.02%74.29%178.22%-878.79%-35.26%-138.29%-270.47%77.13%75.65%17.09%94.29%
Free Cash Flow Growth (3y)FCF Growth (3y)
-14.02%-18.59%27.32%25.36%11.72%61.76%20.21%57.62%
Free Cash Flow Growth (5y)FCF Growth (5y)
-20.37%-45.89%
Free Cash Flow (QoQ)FCF (QoQ)
-71.85%7.22%72.24%-254.36%31.33%53.83%72.65%-95.73%-4.01%240.46%-442.29%72.95%-83.25%-0.48%54.08%71.20%-523.93%93.08%
Gross Margin Growth (1y)
Gross Margin Growth (3y)
Gross Margin (QoQ)
Gross Profit Growth (1y)
Gross Profit Growth (3y)
Gross Profit (QoQ)
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
8.59%-56.28%-140.07%
Net Cash Flow Growth (1y)NCF Growth (1y)
597.55%-939.34%-3,203.04%-1,026.50%-138.41%-51.46%158.34%481.58%-3,263.72%244.17%111.06%-188.22%185.29%-150.00%-263.04%103.70%
Net Cash Flow Growth (3y)NCF Growth (3y)
296.78%-241.86%236.81%-221.37%122.53%-41.54%-26.15%28.56%
Net Cash Flow Growth (5y)NCF Growth (5y)
221.26%-94.80%
Net Cash Flow (QoQ)NCF (QoQ)
25.14%255.89%76.34%123.36%-321.38%-6.26%92.69%382.26%166.05%595.03%-164.45%128.88%63.15%-390.53%162.30%-116.93%-432.02%106.60%
Net Income Growth (1y)
-146.28%-45.39%66.28%88.14%54.72%212.06%142.48%800.99%-498.11%-174.27%-598.17%44.07%346.35%198.14%601.31%489.41%
Net Income Growth (3y)
-8.91%-23.47%10.64%47.33%105.45%41.23%132.75%294.78%
Net Income Growth (5y)
-36.95%-25.17%
Net Income (QoQ)
-22.07%-3.35%34.46%-68.96%70.53%63.64%-150.11%518.18%-88.83%500.00%-313.41%48.08%25.07%273.51%264.92%-79.32%282.76%104.01%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
67.43%88.66%54.36%210.55%145.24%871.52%-508.91%-178.99%-597.53%44.25%346.67%198.23%601.31%488.17%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
9.83%48.30%106.88%41.91%136.83%307.08%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-1.04%32.97%-65.27%70.90%64.83%-169.85%500.34%-88.09%499.74%-312.97%48.07%25.00%273.88%264.20%-79.32%282.76%104.01%
Net Margin Growth (1y)
0.11M0.14M
Net Margin Growth (3y)
0.12M
Net Margin (QoQ)
256.000.05M-0.03M0.08M0.03M
Operating Income Growth (1y)Op. Inc Growth (1y)
53.71%66.80%64.67%68.55%43.13%17.30%-6.77%7.27%-51.92%20.61%21.43%-57.77%18.69%-11.13%
Operating Income Growth (3y)Op. Inc Growth (3y)
26.32%39.81%33.33%22.80%11.10%9.97%
Operating Income Growth (5y)Op. Inc Growth (5y)
Operating Income (QoQ)Op. Inc (QoQ)
-1.47%28.27%-50.52%57.75%27.21%23.69%-34.01%23.60%-5.84%1.47%-16.38%-25.17%44.69%2.49%-133.70%35.49%24.41%
Operating Margin Growth (1y)
0.09M0.11M
Operating Margin Growth (3y)
0.15M
Operating Margin (QoQ)
-443.000.05M-0.02M0.06M0.02M
Profit After Tax Growth (1y)PAT Growth (1y)
66.28%88.14%54.72%208.49%142.48%800.99%-498.11%-176.71%-598.17%44.07%346.35%198.14%601.31%489.41%
Profit After Tax Growth (3y)PAT Growth (3y)
10.64%47.33%105.45%41.23%132.75%294.78%
Profit After Tax Growth (5y)PAT Growth (5y)
Profit After Tax (QoQ)PAT (QoQ)
-3.35%34.46%-68.96%70.53%63.64%-150.11%504.87%-88.46%500.00%-313.41%48.08%25.07%273.51%264.92%-79.32%282.76%104.01%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
1,668.18%301.01%-5.87%130.42%120.28%72.52%7.12%-16.17%-19.05%-22.21%-20.05%-18.07%-15.69%-14.48%-16.05%-16.39%-17.52%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
183.90%185.83%155.81%16.53%14.56%4.70%-10.41%-16.88%-17.43%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
87.03%90.08%91.37%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
-6.27%2.06%-3.02%1.18%24.71%52.34%19.88%-3.28%-2.33%-5.42%-6.19%-6.59%-6.14%-2.79%-3.87%-3.87%-4.81%-4.56%-4.27%-5.17%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M0.00M869.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.00M0.00M0.00M0.01M0.01M0.01M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
Return on Assets [ROA] (QoQ)ROA (QoQ)
-389.000.00M-607.00405.00581.00489.000.00M258.00589.00-816.000.00M-675.00301.000.00M544.000.00M0.00M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M-174.0024.000.00M0.00M0.00M0.00M87.00-224.00-230.0068.0097.00386.00435.00
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
194.00800.000.00M0.00M0.00M0.00M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-531.00-416.00-623.00361.00505.00-218.000.00M157.0081.00-95.00-56.00-154.0075.00203.00-27.00135.00125.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
0.00M0.00M685.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
0.00M0.00M0.00M0.01M0.01M0.01M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
Return on Equity [ROE] (QoQ)ROE (QoQ)
-415.000.00M-659.00444.00645.00255.000.00M294.00590.00-948.000.00M-713.00332.000.00M722.000.00M0.00M
Return on Invested Capital [ROIC] Growth (1y)ROIC Growth (1y)
213.00
Return on Invested Capital [ROIC] Growth (3y)ROIC Growth (3y)
0.00M0.00M
Return on Invested Capital [ROIC] (QoQ)ROIC (QoQ)
-664.00-154.0071.00359.00-62.00
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
0.09M0.11M0.01M0.02M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
0.15M0.10M0.06M0.06M
Return on Sales [ROS] (QoQ)ROS (QoQ)
-443.000.05M-0.02M0.06M0.02M-0.05M-0.01M-0.05M0.00M-0.01M
Revenue Growth (1y)
0.00%0.00%
Revenue Growth (3y)
44.27%
Revenue (QoQ)
1.20%1.19%32.55%-26.33%1.20%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
207.84%439.43%-95.71%-3.29%-72.07%-46.35%647.98%-32.47%-64.67%-10.10%69.17%-34.91%138.87%85.84%-20.69%74.13%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
41.58%92.69%-18.40%-24.81%-38.23%-3.58%115.69%-8.53%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
56.38%61.02%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
138.93%-53.29%62.06%-16.46%-93.21%952.02%-53.19%60.45%-5.34%-5.02%-75.51%308.31%78.11%-63.45%-10.12%217.66%-23.99%-19.76%
Tax Rate (QoQ)
55.00
Total Debt Growth (1y)
-40.00%-98.65%200.00%107,561.43%5,101,200.00%3,203,300.00%-99.95%-99.36%-99.89%-97.14%98.18%
Total Debt Growth (3y)
-21.35%223.96%-75.74%767.13%
Total Debt (QoQ)
22.22%-98.65%6,900.00%-98.57%0.00%200.00%2,512,000.00%-32.31%-37.20%840.00%-89.06%-5.56%-97.06%65,100.00%

Oramed Pharmaceuticals Growth Metrics API

Pull Oramed Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ORMP&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY